Patient-Reported Outcome Measures for Coronary Artery Disease

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byStephen B Wilton, MD, MSc

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Calgary

No Placebo Group

Trial Summary

What is the purpose of this trial?Investigators recently developed the APPROACH electronic patient reported outcome (ePROM) Survey and Clinician Report tools to collect individual results from online quality of life and health status surveys for patients with coronary heart disease, and report them back to their treating clinicians. This pilot interventional study uses a pre-post design to assess whether implementing the ePROM system into routine care is feasible and acceptable to patients and physicians, and to inform feasibility for a larger clinical trial. Specifically, the investigators aim to evaluate use of the ePROM Patient Survey and Clinician Report among eligible outpatients with known or suspected coronary artery disease and their cardiologists. Additionally, the investigators aim to determine if the use of the APPROACH ePROMs Clinician Report in routine medical encounters is acceptable (based on administrative burden, ease of use, and time required) to patients and clinicians, and supports effective communication for management of symptoms of coronary artery disease.

Eligibility Criteria

This trial is for adults over 40 with known or suspected coronary artery disease, who can communicate in English (or have help) and have internet access. They must be seeing a participating cardiologist soon.

Inclusion Criteria

I can communicate in English or have someone who can help me with it.

I have or might have heart artery disease based on my symptoms or past tests.

I am 40 years old or older.

+2 more

Exclusion Criteria

N/A, all inclusion criteria must be met to participate

Participant Groups

The study tests an electronic system where patients report their health status online, which then gets shared with their doctors to improve care for heart conditions.

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Patients in this group will complete the ePROM patient survey in advance of their care visit.

Group II: Control GroupActive Control1 Intervention

Patients in this group will attend their cardiology appointment as normal. No intervention present.